Although there has been considerable progress in reducing cancer incidence in the United
States, the number of cancer survivors continues to increase due to the aging and growth of …

As the population of cancer survivors has grown into the millions, there has been increasing
emphasis on understanding how the late effects of treatment affect survivors' ability to return …

This review summarizes the current literature on cancer-related cognitive impairment (CRCI)
with a focus on prevalence, mechanisms, and possible interventions for CRCI in those who …

Answer questions and earn CME/CNE Over the past few decades, a body of research has
emerged confirming what many adult patients with noncentral nervous system cancer have …

Motivational and motor deficits are common in patients with depression and other psychiatric
disorders, and are related to symptoms of anhedonia and motor retardation. These deficits in …

Cognitive changes associated with cancer and cancer treatments have become an
increasing concern. Using breast cancer as the prototype, we reviewed the research from …

It has become increasingly apparent that cytotoxic drugs given systemically for non-CNS
tumours might have cognitive side-effects, but many fundamental questions require further …

The anthracycline doxorubicin (DOX) is widely used in chemotherapy due to its efficacy in
fighting a wide range of cancers such as carcinomas, sarcomas and hematological cancers …

Objective Patients with breast cancer face cognitive impairment that affects their quality of
life; partially attributable to treatment. Our aim was to detail the prevalence and change of …

Purpose Adjuvant chemotherapy for breast cancer can have adverse effects on cognition
shortly after administration. Whether chemotherapy has any long-term effects on cognition is …